Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LYFE
9526
DELISTED
2ndVote Life Neutral Plus ETF
LYFE
| $326K | ﹤0.01% |
+11,715
| New | +$352K |
|
|
CND
9527
PUT
DELISTED
Concord Acquisition Corp.
CND
| $326K | ﹤0.01% |
32,700
-153,400
| -82% | -$1.53M |
|
9528
CALL
Consolidated Water Co
CWCO
$500M
| $325K | ﹤0.01% |
22,400
-4,000
| -15% | -$49.6K |
|
9529
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $325K | ﹤0.01% |
6,560
-175,298
| -96% | -$8.71M |
|
9530
Hippo Holdings
HIPO
$872M
| $325K | ﹤0.01% |
14,816
-43,472
| -75% | -$1.61M |
|
9531
Pure Cycle
PCYO
$271M
| $325K | ﹤0.01% |
30,789
+8,723
| +40% | +$94.3K |
|
9532
CALL
RLX Technology
RLX
$2.37B
| $325K | ﹤0.01% |
152,800
-127,200
| -45% | -$256K |
|
|
THR
9533
CALL
DELISTED
Thermon Group Holdings
THR
| $325K | ﹤0.01% |
+23,100
| New | +$356K |
|
9534
Innovator US Equity Buffer ETF March
BMAR
$256M
| $324K | ﹤0.01% |
10,461
+4,552
| +77% | +$149K |
|
|
JAMF
9535
PUT
DELISTED
Jamf
JAMF
| $324K | ﹤0.01% |
13,100
-30,600
| -70% | -$858K |
|
9536
Mustang Bio
MBIO
$4.5M
| $324K | ﹤0.01% |
738
+687
| +1,347% | +$380K |
|
9537
CALL
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $324K | ﹤0.01% |
+10,400
| New | +$332K |
|
9538
CALL
Primoris Services
PRIM
$4.48B
| $324K | ﹤0.01% |
14,900
-34,900
| -70% | -$840K |
|
9539
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$133M
| $324K | ﹤0.01% |
+13,367
| New | +$338K |
|
9540
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $324K | ﹤0.01% |
7,565
-9,330
| -55% | -$432K |
|
9541
PUT
Sundial Growers
SNDL
$313M
| $324K | ﹤0.01% |
99,240
-45,620
| -31% | -$202K |
|
9542
CALL
iShares 10-20 Year Treasury Bond ETF
TLH
$10.8B
| $324K | ﹤0.01% |
2,700
+1,100
| +69% | +$135K |
|
|
ORAN
9543
CALL
DELISTED
Orange
ORAN
| $324K | ﹤0.01% |
27,500
+9,700
| +54% | +$116K |
|
9544
American Well
AMWL
$212M
| $323K | ﹤0.01% |
3,745
-30,220
| -89% | -$2.25M |
|
|
CGAU
9545
PUT
Centerra Gold
CGAU
$4.21B
| $323K | ﹤0.01% |
47,900
+3,700
| +8% | +$31.3K |
|
9546
PUT
CleanSpark
CLSK
$3.1B
| $323K | ﹤0.01% |
82,400
-83,100
| -50% | -$559K |
|
9547
VanEck Oil Refiners ETF
CRAK
$258M
| $323K | ﹤0.01% |
+10,877
| New | +$341K |
|
|
GLOP
9548
CALL
DELISTED
GASLOG PARTNERS LP
GLOP
| $323K | ﹤0.01% |
58,200
+6,200
| +12% | +$34K |
|
9549
CALL
Viant Technology
DSP
$275M
| $322K | ﹤0.01% |
63,300
+32,800
| +108% | +$197K |
|
9550
PUT
Dorian LPG
LPG
$2.03B
| $322K | ﹤0.01% |
+21,200
| New | +$336K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.